Circulating Tumor Cells in Early Breast Cancer.
Journal
JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
24
10
2018
revised:
24
02
2019
accepted:
27
03
2019
entrez:
31
7
2019
pubmed:
31
7
2019
medline:
31
7
2019
Statut:
epublish
Résumé
Circulating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the clinical validity of CTC detection in that clinical setting was initially not well recognized. A cytological CTC detection device (CellSearch) fulfilling the CLIA requirements for analytical validity was subsequently developed and, in 2008, we reported the first study (REMAGUS02) showing that distant metastasis-free survival was shorter in early breast cancer patients with one or more CTCs. In the past 10 years, other clinical studies and meta-analyses have established CTC detection as a level-of-evidence 1 prognostic biomarker for local relapses, distant relapses, and overall survival. This review summarizes available data on CTC detection and the promises of this proliferation- and subtype-independent metastasis-associated biomarker in early breast cancer patients.
Identifiants
pubmed: 31360902
doi: 10.1093/jncics/pkz026
pii: pkz026
pmc: PMC6649836
doi:
Types de publication
Journal Article
Langues
eng
Pagination
pkz026Références
Am J Pathol. 2001 Jul;159(1):17-20
pubmed: 11438448
J Clin Oncol. 2001 Aug 15;19(16):3669-74
pubmed: 11504748
Clin Cancer Res. 2004 Feb 15;10(4):1392-400
pubmed: 14977842
Clin Cancer Res. 2004 Oct 15;10(20):6897-904
pubmed: 15501967
Clin Cancer Res. 2004 Dec 15;10(24):8152-62
pubmed: 15623589
N Engl J Med. 2005 Aug 25;353(8):793-802
pubmed: 16120859
Int J Cancer. 2006 Apr 15;118(8):2013-9
pubmed: 16287086
Br J Cancer. 2006 Mar 13;94(5):672-80
pubmed: 16495933
J Clin Pathol. 2008 May;61(5):570-6
pubmed: 18037661
Cancer Cell. 2008 Jan;13(1):58-68
pubmed: 18167340
Br J Cancer. 2008 Jan 29;98(2):512-3; author reply 514
pubmed: 18195708
J Clin Oncol. 2008 Mar 10;26(8):1208-15
pubmed: 18323545
N Engl J Med. 2008 Mar 27;358(13):1409-11
pubmed: 18367751
Clin Cancer Res. 2008 Jun 1;14(11):3306-11
pubmed: 18519757
Science. 2008 Sep 26;321(5897):1841-4
pubmed: 18755941
Clin Cancer Res. 2008 Nov 1;14(21):7004-10
pubmed: 18980996
Ann Oncol. 2009 Nov;20(11):1836-41
pubmed: 19556319
Br J Cancer. 2009 Aug 18;101(4):589-97
pubmed: 19623181
Clin Transl Oncol. 2009 Aug;11(8):544-7
pubmed: 19661030
Breast Cancer Res. 2009;11(4):R59
pubmed: 19664291
Ann Oncol. 2010 Apr;21(4):729-33
pubmed: 19850639
Nat Rev Cancer. 2010 Jan;10(1):2-3
pubmed: 20050335
Clin Cancer Res. 2010 May 1;16(9):2634-45
pubmed: 20406831
Cancer. 2010 Jul 15;116(14):3330-7
pubmed: 20564098
Int J Cancer. 2011 Nov 15;129(10):2522-6
pubmed: 21207426
PLoS One. 2011 Jan 10;6(1):e15624
pubmed: 21264346
Breast Cancer Res Treat. 2012 Feb;132(1):121-9
pubmed: 21562707
Breast Cancer Res. 2011 Jun 14;13(3):R61
pubmed: 21672237
Nat Rev Cancer. 2011 Jun 24;11(7):512-22
pubmed: 21701513
Lancet Oncol. 2012 Apr;13(4):375-84
pubmed: 22377126
Ann Oncol. 2012 Jul;23(7):1744-50
pubmed: 22377561
Lancet Oncol. 2012 Jul;13(7):688-95
pubmed: 22677156
Breast Cancer Res. 2012 Oct 22;14(5):R133
pubmed: 23088337
Int J Breast Cancer. 2013;2013:130470
pubmed: 23762567
PLoS One. 2013 Jun 27;8(6):e67148
pubmed: 23826219
Breast. 2013 Dec;22(6):1060-5
pubmed: 24060577
Lancet Oncol. 2014 Apr;15(4):406-14
pubmed: 24636208
Breast Cancer Res. 2014 Apr 23;16(2):R43
pubmed: 24758318
J Natl Cancer Inst. 2014 May 15;106(5):null
pubmed: 24832787
Breast Cancer Res Treat. 2014 Sep;147(2):345-51
pubmed: 25151295
Breast Cancer Res Treat. 2014 Sep;147(2):325-33
pubmed: 25164970
Int J Oncol. 2015 Jan;46(1):407-13
pubmed: 25339612
Mol Cancer Ther. 2015 Mar;14(3):821-7
pubmed: 25552367
Breast Cancer Res. 2015 Jan 09;17:2
pubmed: 25572591
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S552-8
pubmed: 25968619
BMC Cancer. 2015 Jul 22;15:533
pubmed: 26194471
Breast Cancer Res. 2015 Oct 09;17(1):136
pubmed: 26453190
Clin Cancer Res. 2016 May 15;22(10):2583-93
pubmed: 26733614
J Cancer Res Clin Oncol. 2016 Sep;142(9):1883-95
pubmed: 26825607
Ann Oncol. 2017 Jan 1;28(1):103-109
pubmed: 28177480
J Circ Biomark. 2015 May 5;4:3
pubmed: 28936239
J Natl Cancer Inst. 2018 Jun 1;110(6):560-567
pubmed: 29659933
Cancer Med. 2018 Jun;7(6):2442-2451
pubmed: 29733541
JAMA Oncol. 2018 Aug 1;4(8):e180163
pubmed: 29800954
Ann Oncol. 2018 Aug 1;29(8):1777-1783
pubmed: 29893791
Breast Cancer Res Treat. 2018 Oct;171(3):571-580
pubmed: 29931425
J Clin Oncol. 2018 Sep 1;36(25):2621-2629
pubmed: 30040523
JAMA Oncol. 2018 Dec 1;4(12):1700-1706
pubmed: 30054636
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):389-396
pubmed: 30291993
J Natl Cancer Inst. 2019 Apr 1;111(4):339-341
pubmed: 30312420
J Natl Cancer Inst. 2019 Apr 1;111(4):380-387
pubmed: 30312434